Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
11.19
+0.04 (0.36%)
At close: Sep 8, 2025, 4:00 PM
11.03
-0.16 (-1.43%)
Pre-market: Sep 9, 2025, 6:07 AM EDT
Ginkgo Bioworks Holdings Revenue
Ginkgo Bioworks Holdings had revenue of $49.60M in the quarter ending June 30, 2025, a decrease of -11.75%. This brings the company's revenue in the last twelve months to $230.82M, up 25.21% year-over-year. In the year 2024, Ginkgo Bioworks Holdings had annual revenue of $227.04M, down -9.71%.
Revenue (ttm)
$230.82M
Revenue Growth
+25.21%
P/S Ratio
2.61
Revenue / Employee
$276,757
Employees
834
Market Cap
620.21M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 227.04M | -24.41M | -9.71% |
| Dec 31, 2023 | 251.46M | -226.25M | -47.36% |
| Dec 31, 2022 | 477.71M | 163.87M | 52.21% |
| Dec 31, 2021 | 313.84M | 237.18M | 309.40% |
| Dec 31, 2020 | 76.66M | 22.47M | 41.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
DNA News
- 4 days ago - Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium - Business Wire
- 10 days ago - Ginkgo Bioworks Issues Notice of Settlement of Shareholder Derivative Actions - PRNewsWire
- 19 days ago - Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Partner to Deploy AI-driven Lab-in-the-loop Workflows Across the Biopharma Industry - PRNewsWire
- 27 days ago - Ginkgo Automation Appoints Brian O'Sullivan as Head of Commercial to Accelerate External Growth - PRNewsWire
- 4 weeks ago - Ginkgo Bioworks: Sell The Recent Rally - Seeking Alpha
- 4 weeks ago - Ginkgo Bioworks Holdings, Inc. (DNA) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Ginkgo Bioworks Reports Second Quarter 2025 Financial Results - PRNewsWire
- 5 weeks ago - Ginkgo Bioworks Announces Date of Second Quarter 2025 Results Presentation - PRNewsWire